LSTA (Lisata Therapeutics) Net Margin %: 0.00% (As of Mar. 2026)

What is Lisata Therapeutics Net Margin %?

Lisata Therapeutics LSTA -1.15% 19 Net Margin % is 0.00% as of Mar. 2026. GuruFocus rates LSTA with a GF Score™ of 19/100. The stock has 4 warning signs investors should review. Among 947 Biotechnology companies, Lisata Therapeutics ranks worse than 93.14% on this metric.

Net margin is calculated as Net Income divided by its Revenue. Lisata Therapeutics's Net Income for the three months ended in Mar. 2026 was $-4.49 Mil. Lisata Therapeutics's Revenue for the three months ended in Mar. 2026 was $0.00 Mil. Therefore, Lisata Therapeutics's net margin for the quarter that ended in Mar. 2026 was 0.00%.

The historical rank and industry rank for Lisata Therapeutics's Net Margin % or its related term are showing as below:

LSTA' s Net Margin % Range Over the Past 10 Years
Min: -9756.47 Med: -5877.49 Max: -1998.5
Current: -9618.24

LSTA's Net Margin % is ranked worse than
93.14% of 947 companies
in the Biotechnology industry
Industry Median: -89.56 vs LSTA: -9618.24

Lisata Therapeutics (NAS:LSTA) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Lisata Therapeutics Net Margin % Related Terms

Lisata Therapeutics Net Margin % Historical Data

* Premium members only.

The historical data trend for Lisata Therapeutics's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lisata Therapeutics Net Margin % Chart

Lisata Therapeutics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Net Margin %

Get a 7-Day Free Trial

0.00

-1,998.50

-9,756.47

Lisata Therapeutics Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Net Margin %	Get a 7-Day Free Trial															0.00	-6,655.71	0.00	-2,954.00	0.00

LSTA vs NRSN, SNTI, DYAI: Net Margin % Comparison

For the Biotechnology subindustry, Lisata Therapeutics's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lisata Therapeutics Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lisata Therapeutics's Net Margin % distribution charts can be found below:

* The bar in red indicates where Lisata Therapeutics's Net Margin % falls into.

Save Embed

19GF Score

Lisata Therapeutics Inc LSTA

Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Lisata Therapeutics Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Lisata Therapeutics's Net Margin for the fiscal year that ended in Dec. 2025 is calculated as

Net Margin	=	Net Income (A: Dec. 2025 )	/	Revenue (A: Dec. 2025 )
	=	-16.586	/	0.17
	=	-9,756.47 %

Lisata Therapeutics's Net Margin for the quarter that ended in Mar. 2026 is calculated as

Net Margin	=	Net Income (Q: Mar. 2026 )	/	Revenue (Q: Mar. 2026 )
	=	-4.489	/	0
	=	%

Frequently Asked Questions Learn more about Net Margin % →

What does a Net Margin % of 0.00% mean?

Lisata Therapeutics (LSTA) has a Net Margin % of 0.00% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Lisata Therapeutics and its competitors. According to the industry distribution chart, Lisata Therapeutics ranks #882 out of 947 companies in the Biotechnology industry, placing it in the top 93.1%.

Is Lisata Therapeutics' Net Margin % too high?

Lisata Therapeutics' current Net Margin % is 0.00%. Based on the distribution chart, Lisata Therapeutics ranks #882 out of 947 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Lisata Therapeutics has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.

How does Lisata Therapeutics' Net Margin % compare to NRSN and SNTI?

According to the Biotechnology industry distribution chart, Lisata Therapeutics ranks #882 out of 947 companies for Net Margin %. This places Lisata Therapeutics in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Net Margin % for a Biotechnology company?

A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Net Margin % mean?

A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Lisata Therapeutics and its competitors. Lisata Therapeutics's current Net Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Lisata Therapeutics stock overvalued right now?

Lisata Therapeutics (LSTA) has a current Net Margin % of 0.00%. The current Net Margin % is 0.00%. Lisata Therapeutics' overall GF Score™ is 19/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Net Margin % calculated?

Net Margin % is calculated from a company's financial statements. For Lisata Therapeutics (LSTA), the current Net Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Lisata Therapeutics Business Description

Industry Healthcare Biotechnology

Comparable Companies NRSN SNTI DYAI CELU IGC CRVO NEUP APLM SNSE KYNB VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY RVMD ASX:CSL ONC XKRX:068270

Other Exchanges 0HS8:UK 8NE:Germany

Address 110 Allen Road, 2nd Floor, Basking Ridge, NJ, USA, 07920

Website https://www.lisata.com

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The company has one operating segment, the research and development of its investigational drug product.

19GF Score

Get the complete analysis for LSTA

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.45

Price

View LSTA Analysis

See Net Margin % data for all stocks →